• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

表皮生长因子受体(EGFR)配体结合域的基因变异及其与阿拉伯癌症患者结构改变的关联。

Genetic variants of the EGFR ligand-binding domain and their association with structural alterations in Arab cancer patients.

作者信息

Marzouq Maryam, Nairouz Ali, Ben Khalaf Noureddine, Bourguiba-Hachemi Sonia, Quaddorah Raed, Ashoor Dana, Fathallah M Dahmani

机构信息

Department of Life Sciences, Health Biotechnology Program, College of Graduate Studies, Arabian Gulf University, PO Box 26671, Manama, Kingdom of Bahrain.

King Fahad Chair for Health Biotechnology, College of Graduate Studies, Arabian Gulf University, PO Box 26671, Manama, Kingdom of Bahrain.

出版信息

BMC Res Notes. 2021 Apr 19;14(1):146. doi: 10.1186/s13104-021-05559-y.

DOI:10.1186/s13104-021-05559-y
PMID:33874989
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8054381/
Abstract

OBJECTIVE

This study aimed to identify novel genetic variants in the CR2 extracellular domain of the epidermal growth factor receptor (EGFR) in healthy individuals and patients with six different types of adenocarcinoma, in Arabian peninsula populations. It also aimed to investigate the effects of these variants on the EGFR structure and their eventual relevance to tumorigenesis.

RESULTS

We detected seven new EGFR genetic variants in 168 cancer patients and 114 controls. A SNP rs374670788 was more frequent in bladder cancer but not significantly associated to. However, a missense mutation (V550M) was significantly associated to colon, ovary, lung, bladder and thyroid cancer samples (p < 0.05). Three mutations (H590R, E602K and T605T) were found in the heterozygous form only in colon cancer patients. Genomic analysis of the synonymous mutation (G632G) showed that the T/A genotype could be associated to thyroid cancer in Arab patients (p < 0.05). An additional novel SNP rs571064657 was observed in control individuals. Computational analysis of the genetic variants revealed a reduction in the stabilization of the EGFR tethered form for both V550M and the common R521K variant with low energetic state (- ∆∆G). Molecular interactions analysis suggested that these mutations might affect the receptor's function and promote tumorigenesis.

摘要

目的

本研究旨在识别阿拉伯半岛人群中健康个体及六种不同类型腺癌患者的表皮生长因子受体(EGFR)CR2胞外域的新型基因变异。本研究还旨在调查这些变异对EGFR结构的影响及其与肿瘤发生的最终相关性。

结果

我们在168例癌症患者和114例对照中检测到7种新的EGFR基因变异。单核苷酸多态性rs374670788在膀胱癌中更常见,但无显著相关性。然而,一个错义突变(V550M)与结肠癌、卵巢癌、肺癌、膀胱癌和甲状腺癌样本显著相关(p < 0.05)。三个突变(H590R、E602K和T605T)仅在结肠癌患者中以杂合形式被发现。同义突变(G632G)的基因组分析表明,T/A基因型可能与阿拉伯患者的甲状腺癌相关(p < 0.05)。在对照个体中观察到另一个新的单核苷酸多态性rs571064657。对基因变异的计算分析显示,V550M和常见的R521K变异在低能量状态(-∆∆G)下,EGFR栓系形式的稳定性均降低。分子相互作用分析表明,这些突变可能影响受体功能并促进肿瘤发生。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a307/8054381/07a2b7b69df5/13104_2021_5559_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a307/8054381/07a2b7b69df5/13104_2021_5559_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a307/8054381/07a2b7b69df5/13104_2021_5559_Fig1_HTML.jpg

相似文献

1
Genetic variants of the EGFR ligand-binding domain and their association with structural alterations in Arab cancer patients.表皮生长因子受体(EGFR)配体结合域的基因变异及其与阿拉伯癌症患者结构改变的关联。
BMC Res Notes. 2021 Apr 19;14(1):146. doi: 10.1186/s13104-021-05559-y.
2
Epidermal growth factor receptor and KRAS mutations in lung adenocarcinoma: a retrospective study of the Lebanese population.肺腺癌中表皮生长因子受体和KRAS突变:黎巴嫩人群的回顾性研究
Oncol Rep. 2014 Nov;32(5):2223-9. doi: 10.3892/or.2014.3406. Epub 2014 Aug 14.
3
Germ-line mutations in epidermal growth factor receptor (EGFR) are rare but may contribute to oncogenesis: a novel germ-line mutation in EGFR detected in a patient with lung adenocarcinoma.表皮生长因子受体 (EGFR) 中的种系突变很罕见,但可能有助于肿瘤发生:在肺腺癌患者中检测到的 EGFR 中的一种新的种系突变。
BMC Cancer. 2011 May 16;11:172. doi: 10.1186/1471-2407-11-172.
4
Correlation of E-cadherin gene polymorphisms and epidermal growth factor receptor mutation in lung adenocarcinoma.肺腺癌中 E-钙黏蛋白基因多态性与表皮生长因子受体突变的相关性。
Int J Med Sci. 2018 May 22;15(8):765-770. doi: 10.7150/ijms.24051. eCollection 2018.
5
Potential Impacts of Promoter Polymorphisms on the Mutation Status and Progression of Non-Small Cell Lung Cancer in Taiwan.台湾地区启动子多态性对非小细胞肺癌突变状态和进展的潜在影响。
Genes (Basel). 2021 Mar 17;12(3):427. doi: 10.3390/genes12030427.
6
Targeted sequencing identifies genetic alterations that confer primary resistance to EGFR tyrosine kinase inhibitor (Korean Lung Cancer Consortium).靶向测序可识别出导致对表皮生长因子受体酪氨酸激酶抑制剂产生原发性耐药的基因改变(韩国肺癌联盟)。
Oncotarget. 2016 Jun 14;7(24):36311-36320. doi: 10.18632/oncotarget.8904.
7
CR1/CR2 interactions modulate the functions of the cell surface epidermal growth factor receptor.CR1/CR2相互作用调节细胞表面表皮生长因子受体的功能。
J Biol Chem. 2004 May 21;279(21):22387-98. doi: 10.1074/jbc.M401244200. Epub 2004 Mar 11.
8
The Association between Epidermal Growth Factor Receptor () Gene Polymorphisms and Lung Cancer Risk.表皮生长因子受体()基因多态性与肺癌风险的关联。
Biomolecules. 2018 Jul 13;8(3):53. doi: 10.3390/biom8030053.
9
Effect of WW Domain-Containing Oxidoreductase Gene Polymorphism on Clinicopathological Characteristics of Patients with EGFR Mutant Lung Adenocarcinoma in Taiwan.台湾地区 WW 结构域包含氧化还原酶基因多态性对表皮生长因子受体突变型肺腺癌患者临床病理特征的影响。
Int J Environ Res Public Health. 2021 Dec 13;18(24):13136. doi: 10.3390/ijerph182413136.
10
The Relationship between Long Noncoding RNA H19 Polymorphism and the Epidermal Growth Factor Receptor Phenotypes on the Clinicopathological Characteristics of Lung Adenocarcinoma.长链非编码 RNA H19 多态性与肺腺癌临床病理特征表皮生长因子受体表型的关系。
Int J Environ Res Public Health. 2021 Mar 11;18(6):2862. doi: 10.3390/ijerph18062862.

本文引用的文献

1
Structure and Dynamics of the EGF Receptor as Revealed by Experiments and Simulations and Its Relevance to Non-Small Cell Lung Cancer.实验和模拟揭示的表皮生长因子受体的结构与动力学及其与非小细胞肺癌的相关性。
Cells. 2019 Apr 5;8(4):316. doi: 10.3390/cells8040316.
2
Differences in clinical characteristics and mutational pattern between synchronous and metachronous colorectal liver metastases.同时性和异时性结直肠癌肝转移在临床特征和突变模式上的差异。
Cancer Manag Res. 2018 Aug 27;10:2871-2881. doi: 10.2147/CMAR.S161392. eCollection 2018.
3
SDM: a server for predicting effects of mutations on protein stability.
SDM:一种用于预测突变对蛋白质稳定性影响的服务器。
Nucleic Acids Res. 2017 Jul 3;45(W1):W229-W235. doi: 10.1093/nar/gkx439.
4
Epidermal Growth Factor Receptor Cell Proliferation Signaling Pathways.表皮生长因子受体细胞增殖信号通路
Cancers (Basel). 2017 May 17;9(5):52. doi: 10.3390/cancers9050052.
5
EGFR and SYNE2 are associated with p21 expression and SYNE2 variants predict post-operative clinical outcomes in HBV-related hepatocellular carcinoma.EGFR 和 SYNE2 与 p21 表达相关,SYNE2 变体可预测 HBV 相关肝细胞癌的术后临床结局。
Sci Rep. 2016 Aug 9;6:31237. doi: 10.1038/srep31237.
6
Epidermal growth factor receptor gene polymorphisms are associated with prognostic features of breast cancer.表皮生长因子受体基因多态性与乳腺癌的预后特征有关。
BMC Cancer. 2014 Mar 14;14:190. doi: 10.1186/1471-2407-14-190.
7
The ErbB/HER family of protein-tyrosine kinases and cancer.表皮生长因子受体(ErbB)/HER 家族蛋白酪氨酸激酶与癌症。
Pharmacol Res. 2014 Jan;79:34-74. doi: 10.1016/j.phrs.2013.11.002. Epub 2013 Nov 20.
8
Epidermal growth factor receptor R521K polymorphism shows favorable outcomes in KRAS wild-type colorectal cancer patients treated with cetuximab-based chemotherapy.表皮生长因子受体 R521K 多态性显示在接受西妥昔单抗为基础的化疗的 KRAS 野生型结直肠癌患者中具有良好的结局。
Cancer Sci. 2012 Apr;103(4):791-6. doi: 10.1111/j.1349-7006.2012.02225.x. Epub 2012 Feb 22.
9
LigPlot+: multiple ligand-protein interaction diagrams for drug discovery.LigPlot+:用于药物发现的多种配体-蛋白质相互作用图。
J Chem Inf Model. 2011 Oct 24;51(10):2778-86. doi: 10.1021/ci200227u. Epub 2011 Oct 5.
10
The EGFR R521K polymorphism influences the risk to develop colorectal cancer.EGFR R521K 多态性影响结直肠癌的发病风险。
Cancer Biomark. 2010;8(2):61-5. doi: 10.3233/DMA-2011-0826.